Tvardi Therapeutics Inc.

NASDAQ: TVRD · Real-Time Price · USD
24.30
0.51 (2.14%)
At close: Aug 15, 2025, 3:59 PM
24.00
-1.23%
After-hours: Aug 15, 2025, 04:10 PM EDT

Tvardi Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Net Income
-45.08M -70.87M -67.54M -83.09M -63.08M -32.38M -28.03M
Depreciation & Amortization
150K 192K 216K 664K 587K 545K 521K
Stock-Based Compensation
1.43M 3.35M 3.43M 3.43M 3.43M 85K n/a
Other Working Capital
782K -4.79M -8.17M -3.33M -5.71M 348K 1.87M
Other Non-Cash Items
19.87M 21.52M 16.1M 10.35M 4.99M 3.24M 3.23M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-11.53M -15.1M -14.83M 369K -1.77M 3.12M 4.63M
Operating Cash Flow
-35.16M -60.92M -62.62M -68.28M -55.85M -25.39M -19.64M
Capital Expenditures
-210K -1.05M -1.05M -1.37M -1.16M -323K -323K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a -32.21M -32.21M -55.06M -55.06M -22.85M -22.85M
Sales Maturities Of Investments
23M 82M 77M 120.83M 105.33M 46.33M 46.33M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
22.79M 48.74M 43.74M 64.4M 49.11M 23.16M 23.16M
Debt Repayment
-1.91M -3.6M -1.99M -1.29M -685K n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a n/a n/a
Financial Cash Flow
-1.91M -3.6M -1.99M -179K 431K 1.12M 1.12M
Net Cash Flow
-12.78M -14.28M -19.37M -4.07M -6.31M -1.12M 4.63M
Free Cash Flow
-35.37M -61.96M -63.67M -69.65M -57.01M -25.72M -19.97M